pharmaphorum22 天
Boehringer's Spiolto tops Seretide in head-to-head COPD trial
Boehringer Ingelheim's recently-approved Spiolto is more effective than GlaxoSmithKline's Seretide/Advair in improving lung function in patients with chronic obstructive pulmonary disease (COPD ...